Atlassian Co-Founder Scott Farquhar Sold $2.1M of TEAM Just Before Earnings — But the Ownership Story Is Bigger
Scott Farquhar sold about $2.06 million of Atlassian stock over two January 2026 trading days, yet 13G data still points to founder-level beneficial ownership at TEAM.
Scott Farquhar sold about $2.06 million of Atlassian (TEAM) stock across 13 small-lot transactions on January 27 and January 28, just days before the software company reported another quarter of 20%+ revenue growth. The filings matter because Farquhar is no ordinary director: the Atlassian co-founder remains a 10% owner on Form 4, and his November 2024 Schedule 13G/A tied him to roughly 49% beneficial ownership even after years of steady liquidity sales.
That makes this a founder-liquidity story, not a control-exit story. Farquhar stepped down as Atlassian's co-CEO in 2024, leaving Mike Cannon-Brookes to run the company solo, but the co-founders are still central to the Atlassian equity narrative. 13F Insight has already covered the broader founder pattern in one January selloff breakdown and a later look at the co-founders' coordinated selling history. This latest cluster adds a tighter question: why did Farquhar trim stock right before an earnings print that still showed solid top-line momentum?
The two-day sale cluster
| Date | Lots | Shares Sold | Estimated Value | Direct Shares After |
|---|---|---|---|---|
| 2026-01-27 | 8 | 7,665 | $1.02M | 337,260 |
| 2026-01-28 | 5 | 7,665 | $1.04M | 329,595 |
| Total | 13 | 15,330 | $2.06M | 329,595 |
The pattern looks deliberately mechanical. Both days landed at exactly 7,665 shares in aggregate, but were split across multiple executions at slightly different prices, a classic sign of staged market sales rather than a one-shot block trade. For readers tracking Form 4s, that distinction matters: these filings look much closer to systematic liquidity management than a sudden signal that the founder thesis around TEAM has cracked.
Why the timing stands out
Atlassian reported fiscal Q2 2026 results on February 5, about a week after these sales. Revenue rose 23% year over year to $1.586 billion, cloud revenue topped $1.067 billion, and management guided for about 22% full-year revenue growth. In other words, Farquhar sold into a period when the operating story still looked healthy on the surface.
But the market backdrop was less forgiving. Coverage around the quarter showed growing investor anxiety about software multiples, AI monetization, and whether companies like Atlassian could hold premium valuations while also investing aggressively in new AI products. That pressure mattered more because Atlassian had already reshaped leadership: Farquhar was no longer co-CEO, and Cannon-Brookes was carrying the public operating narrative alone. The stock's later slide toward a 52-week low shows how quickly that tension between revenue growth and valuation compression became the real story.
Founder control did not disappear with these sales
Here is the part raw transaction headlines usually miss. Farquhar's latest Form 4 still showed 329,595 directly held shares after the January 28 sales. More importantly, 13F Insight's cached 13D/G data shows a November 2024 Schedule 13G/A linking Farquhar to about 49% beneficial ownership in Atlassian. That means investors should read these January filings as incremental monetization by a founder who still sits deep inside the company's ownership structure, not as a clean break from the business.
That ownership context is why insider stories at multi-founder software companies need more than a transaction ledger. We have made that point elsewhere in coverage of executives with ongoing control or structured ownership, including pieces on Arista co-founder Kenneth Duda and Zoom founder Eric Yuan. The key question is not just how much was sold this week, but how much influence and exposure remain after the filing hits.
Key facts
| Insider | Scott Farquhar |
|---|---|
| Company | Atlassian (TEAM) |
| Current role in filings | Director and 10% owner; former co-CEO and co-founder |
| Recent sale window | January 27-28, 2026 |
| Recent shares sold | 15,330 |
| Recent estimated value | $2.06M |
| Direct shares after latest sale | 329,595 reported on Form 4 |
| Career transactions | 5,387 |
| Career sell value | $1.27B |
| Beneficial ownership context | Schedule 13G/A data for 2024 showed about 49% ownership |
What to watch next
- TEAM stock after the next earnings cycle — if revenue keeps growing above 20% but the multiple keeps compressing, founder sales will look more like prudent diversification than a bearish call.
- Mike Cannon-Brookes' next Form 4 — another mirrored disposal pattern would reinforce the view that Atlassian's founders are following a coordinated liquidity rhythm.
- Future beneficial ownership filings — readers who want the ownership layer, not just the trade tape, should keep an eye on new 13G updates and our explainer on how 13D/G filing dates change the signal.
- Whether direct ownership keeps stepping down in fixed increments — repeated 7,665-share sales would make this look increasingly formulaic, similar to other founder monetization programs tracked across 13F Insight.
- How investors interpret the leadership transition — with Farquhar off the CEO line but still economically significant, the market may separate operational accountability from founder ownership much more aggressively in 2026.
For readers comparing insider prints across software founders, our broader explainers on position sizing and 13D/G timing are useful framing tools. They will not tell you whether to buy or sell TEAM, but they do explain why a $2 million founder sale can be less important than the ownership architecture still sitting behind it.
Related Research
Explore all researchVictory Capital kept mega-cap tech on top in Q4 2025, but the sharper signal was in the secondary moves: large increases in Netflix, Constellation Energy, TSMC and new positions like IQVIA. The next filing will show whether that diversification continues.
Apr 17, 2026
Raymond James used Q4 2025 to keep broad ETF exposure high through VOO, AGG, SPY and IEFA while also adding to sector sleeves such as XLK and XLE. The next filing will show whether that balanced ETF-heavy structure remains the preferred setup.
Apr 17, 2026
Fisher’s Q4 2025 filing was still packed with mega-cap tech, but the bigger tell was a giant Treasury and investment-grade corporate bond sleeve built through IEF and VCIT. The next filing will show whether that duration bet was tactical or structural.
Apr 17, 2026
Dodge & Cox’s Q4 2025 filing barely moved on headline AUM, but the underlying changes were more interesting: fresh positions in Brookfield, TransUnion and PDD inside a still-diversified value book. The next filing will show whether those adds were conviction moves or just incremental reshuffling.
Apr 17, 2026
AQR’s Q4 2025 filing kept expanding, with AUM rising to $190.63B, 69 new names, and a dramatic Bristol Myers build inside an already broad book. The next filing will show whether the quant giant keeps pressing this expansion or starts normalizing the roster again.
Apr 17, 2026